First-mover advantage in the $927M hemp animal feed market. Regulatory catalyst timeline: 2027-2028.
Spent hemp biomass is the highest-protein, most nutrient-dense livestock feed ever tested, currently sitting in landfills because it lacks FDA approval. Oregon State research (June 2025) solved the THC residue concern by proving cannabinoids clear completely within 15 days, removing the primary regulatory barrier. The hemp animal feed market is $657M today, but spent hemp biomass has ZERO commercial market share because it's not approved. FDA approval (expected 2027-2028) transforms spent hemp biomass from waste product to premium feed ingredient. Companies with processing infrastructure, farmer relationships, and distribution channels before approval will capture the arbitrage.
Cold-pressed byproduct after oil extraction. High protein, but lower than spent biomass.
47% protein content - highest in industry. Currently waste product. Post-approval: dominant market position likely.
Hemp stalk meal, oil, cake, and other byproducts. Fragmented market.
INVESTMENT STRATEGY
Capital deployed during regulatory approval phase to build infrastructure and secure supply agreements before market activation. First-mover advantage maximized by operational readiness at approval date.
FDA approval timeline uncertain. While Oregon State research (2025) solved the THC barrier and HEMP Act (2026) establishes framework, approval could take longer than projected 2027-2028 timeline. Mitigation: Infrastructure buildout provides value regardless of exact timing.
Farmer adoption rates uncertain. Competition from traditional feed. Pricing pressure post-approval. Mitigation: Superior nutritional profile (47% protein) and cost advantage (waste product → premium feed) provide strong value proposition.
Processing infrastructure capital requirements. Quality control (THC levels). Withdrawal period management. Traceability systems. Mitigation: Experienced team, proven processing technology, established supply relationships.
We're seeking strategic partners and institutional investors who understand the regulatory arbitrage opportunity. Contact us for the full investment deck and financial projections.
INVESTOR INQUIRIES
Qualified institutional investors and accredited investors only. All investment opportunities subject to regulatory approval and compliance.